EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway

Zechao Qu, Jing Wang, Xiaohao Wang, Lingfei Mo, Hanchao Li, Xinyi Liu, Xiawei Chai, Liang Yan, Yuanyuan Li

Inflammation · 11.03.2026 · 49 (1)

DOI: 10.1007/s10753-026-02488-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, online erschienen am 11.03.2026. Verfasst von Zechao Qu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, TYK2 Kinase, Fibroblasts, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Medical Research Project of Xi'an Science and Technology Bureau, he Shaanxi Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorTYK2 KinaseFibroblastsProto-Oncogene Proteins c-aktSynovial MembraneAnimalsSignal TransductionMicePhosphatidylinositol 3-KinasesArthritis, ExperimentalHumansArthritis, RheumatoidCell MovementCell ProliferationApoptosisTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

DeucravacitinibPI3K/AKTTYK2/STAT3fibroblast-like synoviocytesrheumatoid arthritis

Substanzen

STAT3 Transcription FactorTYK2 KinaseProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
  • Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, 710061, China.
  • School of Medicine, Northwest University, Xi'an, 710069, China.
  • Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. yanliangdr5583@163.com.
  • Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, 710061, China. wudui220@163.com.

Förderung

  • the National Natural Science Foundation of China
  • Medical Research Project of Xi'an Science and Technology Bureau
  • he Shaanxi Province Natural Science Foundation
  • First Affiliated Hospital of Xi'an JiaoTong University Foundation
  • Medical Research Project of Xi’an Science and Technology Bureau
  • First Affiliated Hospital of Xi’an JiaoTong University Foundation

Zitieren

APA

Qu, Z., Wang, J., Wang, X., Mo, L., Li, H., Liu, X., Chai, X., Yan, L., & Li, Y. (2026). Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway. Inflammation, 49(1). https://doi.org/10.1007/s10753-026-02488-5

Vancouver

Qu Z, Wang J, Wang X, Mo L, Li H, Liu X, et al. Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway. Inflammation. 2026;49(1). doi:10.1007/s10753-026-02488-5

BibTeX
@article{Qu2026,
  author = {Qu, Zechao and Wang, Jing and Wang, Xiaohao and Mo, Lingfei and Li, Hanchao and Liu, Xinyi and Chai, Xiawei and Yan, Liang and Li, Yuanyuan},
  title = {Deucravacitinib Inhibits Synovial Fibroblast Activation Via TYK2/STAT3 and PI3K/Akt Signaling Pathway},
  journal = {Inflammation},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10753-026-02488-5}
}
Kostenlos starten →